Received Nov 7, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HIBV | HIB (HIBERIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 35FA4 | — |
Diluent only administration; Diluent only administration; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate preparation of medication in a 3-month-old male patient who received Hib (Hiberix) (batch number 35FA4) for prophylaxis. On 07-OCT-2025, the patient received Hiberix. On 07-OCT-2025, an unknown time after receiving Hiberix, the patient experienced inappropriate preparation of medication (Verbatim: Diluent only administration) and inappropriate dose of vaccine administered (Verbatim: Diluent only administration). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. Additional Information: GSK Receipt Date: 24-OCT-2025 The patient received only the Hiberix diluent. No further details were provided.